Complement proteins regulating macrophage polarisation on biomaterials

[EN] One of the events occurring when a biomaterial is implanted in an host is the protein deposition onto its surface, which might regulate cell responses. When a biomaterial displays a compromised biocompatibility, distinct complement pathways can be activated to produce a foreign body reaction. In this article, we have designed different types of biomaterial surfaces to study the inflammation process. Here, we used different concentrations of (3-glycidoxypropyl)-trimethoxysilane (GPTMS), an organically-modified alkoxysilane as a precursor for the synthesis of various types of sol-gel materials functionalizing coatings for titanium implants to regulate biological responses. Our results showed that greater GPTMS surface concentrations induced greater secretion of TNF-alpha and IL-10 on RAW 264.7 macrophages. When implanted into rabbit tibia, osseointegration decreased with higher GPTMS concentrations. Interestingly, higher deposition of complement-related proteins C-reactive protein (CRP) and ficolin-2 (FCN2), two main activators of distinct complement pathways, was observed. Taking all together, inflammatory potential increase seems to be GPTMS concentration-dependent. Our results show that a greater adsorption of complement proteins can condition macrophage polarization.This work was supported by MINECO [MAT2017-86043-R]; Universitat Jaume I [Predoc/2014/25, UJI-B2017-37]; Basque Government [IT611-13, Predoc/2016/1/0141]; University of the Basque Country [UFI11/56]; CIC bioGUNE is supported by Basque Department of Industry, Tourism and Trade (Etortek and Elkartek programs), ProteoRed-ISCIII [PRB3 IPT17/0019]; CIBERehd Network and Severo Ochoa Grant [SEV-2016-0644]. Authors would like to thank Antonio Coso and Jaime Franco (GMI-Ilerimplant) for their inestimable contribution to this study, and Raquel Oliver, Jose Ortega (UJI), René van Rheden, Vicent Cuijpers (Radboudumc) and Iraide Escobes (CIC bioGUNE) for their valuable technical assistance.Araújo-Gomes, N.; Romero-Gavilán, F.; Zhang, Y.; Martínez-Ramos, C.; Elortza, F.; Azkargorta, M.; Martín De Llano, JJ.... (2019). Complement proteins regulating macrophage polarisation on biomaterials. Colloids and Surfaces B Biointerfaces. 181:125-133. https://doi.org/10.1016/j.colsurfb.2019.05.039S12513318

The effect of strontium incorporation into sol-gel biomaterials on their protein adsorption and cell interactions

[EN] It is known strontium can both inhibit the osteoclast formation and stimulate the osteoblast maturation, so biomaterials containing this element can favour bone structure stabilisation. The addition of Sr to biomaterials could affect their interactions with proteins and cells. Here, a silica-hybrid sol-gel network doped with different amounts of SrCl2 and applied as coatings on titanium discs was examined. in vitro analysis was performed to determine the potential effect of Sr in the coatings, showing enhanced gene expression of osteogenic markers (alkaline phosphatase and transforming growth factor-beta) in MC3T3-E1 incubated with Sr-doped biomaterials. The examination of inflammatory markers (tumour necrosis factor-alpha and interleukin 10) in RAW 264.7 macrophages revealed an anti-inflammatory potential of these materials. Proteins adsorbed onto the coatings incubated with human serum (3 h at 37 degrees C) were also analysed; mass spectrometry was used to characterise the proteins adhering to materials with different Sr content. Adding Sr to the coatings increased their affinity to APOE and VTNC proteins (associated with anti-inflammatory and osteogenic functions). Moreover, the proteins involved in coagulation processes, such as prothrombin, were more abundant on the coatings containing Sr than on the base sol-gel surfaces. Correlations between gene expression and proteomic results were also examined.This work was supported by MINECO (MAT2017-86043-R); Universitat Jaume I (grant numbers Predoc/2014/25, UJI-B2017-37); Basque Government (grant numbers IT611-13, Predoc/2016/1/0141), and University of the Basque Country (UFI11/56). Authors would like to thank Antonio Coso and Jaime Franco (GMI-Ilerimplant) for their inestimable contribution to this study, and Raquel Oliver, Jose Ortega (UJI), and Iraide Escobes (CIC bioGUNE) for their valuable technical assistance.Romero-Gavilán, F.; Araújo-Gomes, N.; García-Arnáez, I.; Martínez-Ramos, C.; Elortza, F.; Azkargorta, M.; Iloro, I.... (2019). The effect of strontium incorporation into sol-gel biomaterials on their protein adsorption and cell interactions. Colloids and Surfaces B Biointerfaces. 174:9-16. https://doi.org/10.1016/j.colsurfb.2018.10.075S91617

Proteomic analysis of calcium-enriched sol-gel biomaterials

[EN] Calcium is an element widely used in the development of biomaterials for bone tissue engineering as it plays important roles in bone metabolism and blood coagulation. The Ca ions can condition the microenvironment at the tissue-material interface, affecting the protein deposition process and cell responses. The aim of this study was to analyze the changes in the patterns of protein adsorption on the silica hybrid biomaterials supplemented with different amounts of CaCl2, which can function as release vehicles. This characterization was carried out by incubating the Ca-biomaterials with human serum. LC-MS/MS analysis was used to characterize the adsorbed protein layers and compile a list of proteins whose affinity for the surfaces might depend on the CaCl2 content. The attachment of pro- and anti-clotting proteins, such as THRB, ANT3, and PROC, increased significantly on the Ca-materials. Similarly, VTNC and APOE, proteins directly involved on osteogenic processes, attached preferentially to these surfaces. To assess correlations with the proteomic data, these formulations were tested in vitro regarding their osteogenic and inflammatory potential, employing MC3T3-E1 and RAW 264.7 cell lines, respectively. The results confirmed a Ca dose-dependent osteogenic and inflammatory behavior of the materials employed, in accordance with the protein attachment patterns.This work was supported by MINECO [MAT2017-86043-R]; Universitat Jaume I [Grant numbers Predoc/2014/25, UJI-B2017-37]; Basque Government [Grant numbers IT611-13, Predoc/2016/1/0141]; University of the Basque Country [Grant number UFI11/56]. CIC bioGUNE is supported by Basque Department of Industry, Tourism and Trade (Etortek and Elkartek programs), the Innovation Technology Department of the Bizkaia County; The ProteoRed-ISCIII (Grant PRB3 IPT17/0019); CIBERehd Network, and Severo Ochoa Grant (SEV-2016-0644). Authors would like to thank Antonio Coso and Jaime Franco (GMI-Ilerimplant) for their inestimable contribution to this study, and Raquel Oliver, Jose Ortega (UJI) and Iraide Escobes (CIC bioGUNE) for their valuable technical assistance.Romero-Gavilán, F.; Araújo-Gomes, N.; Cerqueira, A.; García-Arnáez, I.; Martínez-Ramos, C.; Azkargorta, M.; Iloro, I.... (2019). Proteomic analysis of calcium-enriched sol-gel biomaterials. JBIC Journal of Biological Inorganic Chemistry. 24(4):563-574. https://doi.org/10.1007/s00775-019-01662-5S563574244Berridge MJ, Bootman MD, Lipp P (1998) Calcium—a life and death signal. Nature 395:645–648. https://doi.org/10.1038/27094Hoppe A, Güldal NS, Boccaccini AR (2011) A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 32:2757–2774. https://doi.org/10.1016/j.biomaterials.2011.01.004Flynn A (2003) The role of dietary calcium in bone health. Proc Nutr Soc 62:851–858. https://doi.org/10.1079/PNS2003301Marie PJ (2010) The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone 46:571–576. https://doi.org/10.1016/j.bone.2009.07.082Honda Y, Fitzsimmons RJ, Baylink DJ, Mohan S (1995) Effects of extracellular calcium on insulin-like growth factor II in human bone cells. J Bone Miner Res 10:1660–1665. https://doi.org/10.1002/jbmr.5650101108Koori K, Maeda H, Fujii S et al (2014) The roles of calcium-sensing receptor and calcium channel in osteogenic differentiation of undifferentiated periodontal ligament cells. Cell Tissue Res 357:707–718. https://doi.org/10.1007/s00441-014-1918-5Habibovic P, Barralet JE (2011) Bioinorganics and biomaterials: bone repair. Acta Biomater 32:3013–3026. https://doi.org/10.1016/j.actbio.2011.03.027Oshiro Junior J, Paiva Abuçafy M, Berbel Manaia E et al (2016) Drug delivery systems obtained from silica based organic-inorganic hybrids. Polymers (Basel) 8:91. https://doi.org/10.3390/polym8040091Jones JR (2015) Reprint of: review of bioactive glass: from hench to hybrids. Acta Biomater 23:S53–S82. https://doi.org/10.1016/j.actbio.2015.07.019Romero-Gavilán F, Barros-Silva S, García-Cañadas J et al (2016) Control of the degradation of silica sol-gel hybrid coatings for metal implants prepared by the triple combination of alkoxysilanes. J Non Cryst Solids 453:66–73. https://doi.org/10.1016/j.jnoncrysol.2016.09.026Martínez-Ibáñez M, Juan-Díaz MJ, Lara-Saez I et al (2016) Biological characterization of a new silicon based coating developed for dental implants. J Mater Sci Mater Med 27:80. https://doi.org/10.1007/s10856-016-5690-9Martínez-Ibáñez M, Murthy NS, Mao Y et al (2018) Enhancement of plasma protein adsorption and osteogenesis of hMSCs by functionalized siloxane coatings for titanium implants. J Biomed Mater Res Part B Appl Biomater 106:1138–1147. https://doi.org/10.1002/jbm.b.33889Salinas AJ, Merino JM, Babonneau F et al (2007) Microstructure and Macroscopic Properties of Bioactive CaO–SiO2–PDMS Hybrids. J Biomed Mater Res B Appl Biomater 81B:274–282. https://doi.org/10.1002/jbm.b.30663Almeida JC, Wacha A, Gomes PS et al (2016) A biocompatible hybrid material with simultaneous calcium and strontium release capability for bone tissue repair. Mater Sci Eng, C 62:429–438. https://doi.org/10.1016/j.msec.2016.01.083Valliant EM, Romer F, Wang D et al (2013) Bioactivity in silica/poly(c-glutamic acid) sol-gel hybrids through calcium chelation. Acta Biomater 9:7662–7671. https://doi.org/10.1016/j.actbio.2013.04.037Shirosaki Y, Tsuru K, Hayakawa S et al (2005) In vitro cytocompatibility of MG63 cells on chitosan-organosiloxane hybrid membranes. Biomaterials 26:485–493. https://doi.org/10.1016/j.biomaterials.2004.02.056Romero-Gavilán F, Gomes NC, Ródenas J et al (2017) Proteome analysis of human serum proteins adsorbed onto different titanium surfaces used in dental implants. Biofouling 33:98–111. https://doi.org/10.1080/08927014.2016.1259414Hirsh SL, McKenzie DR, Nosworthy NJ et al (2013) The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates. Colloids Surfaces B Biointerfaces 103:395–404. https://doi.org/10.1016/j.colsurfb.2012.10.039Chen Z, Klein T, Murray RZ et al (2015) Osteoimmunomodulation for the development of advanced bone biomaterials. Mater Today 19:304–321. https://doi.org/10.1016/j.mattod.2015.11.004Araújo-Gomes N, Romero-Gavilán F, García-Arnáez I et al (2018) Osseointegration mechanisms: a proteomic approach. J Biol Inorg Chem 23:459–470. https://doi.org/10.1007/s00775-018-1553-9Romero-Gavilán F, Sanchez-Pérez AM, Araújo-Gomes N et al (2017) Proteomic analysis of silica hybrid sol-gel coatings: a potential tool for predicting the biocompatibility of implants in vivo. Biofouling 33:676–689. https://doi.org/10.1080/08927014.2017.1356289Araújo-Gomes N, Romero-Gavilán F, Sanchez-Pérez AM et al (2018) Characterization of serum proteins attached to distinct sol-gel hybrid surfaces. J Biomed Mater Res Part B Appl Biomater 106:1477–1485. https://doi.org/10.1002/jbm.b.33954Romero-Gavilan F, Araújo-Gomes N, Sánchez-Pérez AM et al (2017) Bioactive potential of silica coatings and its effect on the adhesion of proteins to titanium implants. Colloids Surfaces B Biointerfaces 162:316–325. https://doi.org/10.1016/j.colsurfb.2017.11.072Shiu HT, Goss B, Lutton C et al (2014) Formation of blood clot on biomaterial implants influences bone healing. Tissue Eng Part B Rev 20:697–712. https://doi.org/10.1089/ten.teb.2013.0709Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6:3–8. https://doi.org/10.1038/NMETH.1322Dvorak MM, Riccardi D (2004) Ca2 + as an extracellular signal in bone. Cell Calcium 35:249–255. https://doi.org/10.1016/j.ceca.2003.10.014Cho NH, Seong SY (2009) Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin. Immunology 128:479–486. https://doi.org/10.1111/j.1365-2567.2008.03002.xMeerasa A, Huang JG, Gu FX (2013) Human serum lipoproteins influence protein deposition patterns on nanoparticle surfaces. ACS Appl Mater Interfaces 5:489–493. https://doi.org/10.1021/am302554qBaitsch D, Bock HH, Engel T et al (2011) Apolipoprotein e induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol 31:1160–1168. https://doi.org/10.1161/ATVBAHA.111.222745Niemeier A, Schinke T, Heeren J, Amling M (2012) The role of Apolipoprotein E in bone metabolism. Bone 50:518–524. https://doi.org/10.1016/j.bone.2011.07.015Kim WS, Kim HJ, Lee ZH et al (2013) Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB. Exp Cell Res 319:436–446. https://doi.org/10.1016/j.yexcr.2012.12.004Emsley J, White HE, O’Hara BP et al (1994) Structure of pentameric human serum amyloid P component. Nature 367:338–345Poulsen ET, Pedersen KW, Marzeda AM, Enghild JJ (2017) Serum amyloid P component (SAP) interactome in human plasma containing physiological calcium levels. Biochemistry 56:896–902. https://doi.org/10.1021/acs.biochem.6b01027Bottazzi B, Inforzato A, Messa M et al (2016) The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J Hepatol 64:1416–1427. https://doi.org/10.1016/j.jhep.2016.02.029Mollnes TE, Kirschfink M (2006) Strategies of therapeutic complement inhibition. Mol Immunol 43:107–121. https://doi.org/10.1016/j.molimm.2005.06.014Gessmann J, Seybold D, Peter E et al (2013) Plasma clots gelled by different amounts of calcium for stem cell delivery. Langenbeck’s Arch Surg 398:161–167. https://doi.org/10.1007/s00423-012-1015-8Scheraga HA (2004) The thrombin-fibrinogen interaction. Biophys Chem 112:117–130. https://doi.org/10.1016/j.bpc.2004.07.011Chu AJ (2010) Blood coagulation as an intrinsic pathway for proinflammation: a mini review. Inflamm Allergy Drug Targets 9:32–44. https://doi.org/10.2174/187152810791292890Suleiman L, Négrier C, Boukerche H (2013) Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol 88:637–654. https://doi.org/10.1016/j.critrevonc.2013.07.004Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359:938–949. https://doi.org/10.1056/NEJMra0801082Biltoft D, Gram JB, Larsen A et al (2017) Fast form alpha-2-macroglobulin—a marker for protease activation in plasma exposed to artificial surfaces. Clin Biochem 50:1203–1208. https://doi.org/10.1016/j.clinbiochem.2017.09.002Cvirn G, Gallistl S, Koestenberger M et al (2002) Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res 105:433–439. https://doi.org/10.1016/S0049-3848(02)00042-7Vogler EA, Siedlecki CA (2009) Contact activation of blood-plasma coagulation. Biomaterials 30:1857–1869. https://doi.org/10.1016/j.biomaterials.2008.12.041Leavesley DI, Kashyap AS, Croll T et al (2013) Vitronectin—master controller or micromanager? IUBMB Life 65:807–818. https://doi.org/10.1002/iub.1203Kundu AK, Putnam AJ (2006) Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. Biochem Biophys Res Commun 347:347–357. https://doi.org/10.1016/j.bbrc.2006.06.110Cacchioli A, Ravanetti F, Bagno A et al (2009) Human vitronectin-derived peptide covalently grafted onto titanium surface improves osteogenic activity: a pilot in vivo study on rabbits. Tissue Eng Part A 15:2017–2026. https://doi.org/10.1089/ten.tea.2008.054

An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values

Objectives Discrete choice experiments (DCEs) can be used to obtain latent scale values for the EQ-5D-Y, but these require anchoring at 0 = dead to meet the conventions of quality-adjusted life year (QALY) estimation. The primary aim of this study is to compare four preference elicitation methods for obtaining anchors for latent scale EQ-5D-Y values. Methods Four methods were tested: visual analogue scale (VAS), DCE (with a duration attribute), lag-time time trade-off (TTO) and the location-of-dead (LOD) approach. In computer-assisted personal interviews, UK general public respondents valued EQ-5D-3L health states from an adult perspective and EQ-5D-Y health states from a 10-year-old child perspective. Respondents completed valuation tasks using all four methods, under both perspectives. Results 349 interviews were conducted. Overall, respondents gave lower values under the adult perspective compared to the child perspective, with some variation across methods. The mean TTO value for the worst health state (33333) was about equal to dead in the child perspective and worse than dead in the adult perspective. The mean VAS rescaled value for 33333 was also higher in the child perspective. The DCE produced positive child perspective values and negative adult perspective values, though the models were not consistent. The LOD median rescaled value for 33333 was negative under both perspectives and higher in the child perspective. Discussion There was broad agreement across methods. Potential criteria for selecting a preferred anchoring method are presented. We conclude by discussing the decision-making circumstances under which utilities and QALY estimates for children and adults need to be commensurate to achieve allocative efficiency

Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 Study

Background: The risk of pulmonary embolism (PE) has not been studied in older patients affected by COVID-19. We aimed to assess PE incidence and risk factors in a population of older patients infected with SARS-CoV-2. Methods: An ambispective, observational cohort study. A total of 305 patients >= 75 years old had the SARS-CoV-2 infection from March to May 2020. The incidence rate of PE was estimated as the proportion of new cases within the whole sample. Youden's index was used to assess the cutoff point of D-dimer. To select factors associated with the risk of PE, time-to-event analyses were performed using cause-specific hazard models. Results: In total, 305 patients with a median age of 87 years (62.3% female) were studied; 67.9% were referred from nursing homes and 90.4% received any type of anticoagulation. A total of 64.9% showed frailty and 44% presented with dementia. The PE incidence was 5.6%. The cutoff value of a D-dimer level over 2.59 mg/L showed a sensitivity of 82.4% and specificity of 73.8% in discriminating a PE diagnosis. In the multivariate analysis, the factors associated with PE were previous oncological events and D-dimer levels. Conclusions: The PE incidence was 5.6%, and major risk factors for PE were oncological antecedents and increased plasma D-dimer levels.This work was partially supported by grants (to M.Q.-F., J.G.-P.) from the "New announcement for extraordinary initiative fund UAX-Santander COVID-19," Alfonso X el Sabio University

Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states - Springer

__Abstract__ __Objective__ : To evaluate two different methods to obtain a dead (0)—full health (1) scale for EQ-5D-5L valuation studies when using discrete choice (DC) modeling. __Method__ : The study was carried out among 400 respondents from Barcelona who were representative of the Spanish population in terms of age, sex, and level of education. The DC design included 50 pairs of health states in five blocks. Participants were forced to choose between two EQ-5D-5L states (A and B). Two extra questions concerned whether A and B were considered worse than dead. Each participant performed ten choice exercises. In addition, values were collected using lead-time trade-off (lead-time TTO), for which 100 states in ten blocks were selected. Each participant performed five lead-time TTO exercises. These consisted of DC models offering the health state ‘dead’ as one of the choices—for which all participants’ responses were used (DCdead)—and a model that included only the responses of participants who chose at least one state as worse than dead (WTD) (DCWTD). The study also estimated DC models rescaled with lead-time TTO data and a lead-time TTO linear model. __Results__ : The DCdead and DCWTD models produced relatively similar results, although the coefficients in the DCdead model were slightly lower. The DC model rescaled with lead-time TTO data produced higher utility decrements. Lead-time TTO produced the highest utility decrements. __Conclusions__: The incorporation of the state ‘dead’ in the DC models produces results in concordance with DC models that do not include ‘dead’

The Indonesian EQ-5D-5L Value Set

Background: The EQ-5D is one of the most used generic health-related quality-of-life (HRQOL) instruments worldwide. To make the EQ-5D suitable for use in economic evaluations, a societal-based value set is needed. Indonesia does not have such a value set. Objective: The aim of this study was to derive an EQ-5D-5L value set from the Indonesian general population. Methods: A representative sample aged 17 years and over was recruited from the Indonesian general population. A multi-stage stratified quota method with respect to residence, gender, age, level of education, religion and ethnicity was utilized. Two elicitation techniques, the composite time trade-off (C-TTO) and discrete choice experiments (DCE) were applied. Interviews were undertaken by trained interviewers using computer-assisted face-to-face interviews with the EuroQol Valuation Technology (EQ-VT) platform. To estimate the value set, a hybrid regression model combining C-TTO and DCE data was used. Results: A total of 1054 respondents who completed the interview formed the sample for the analysis. Their characteristics were similar to those of the Indonesian population. Most self-reported health problems were observed in the pain/discomfort dimension (39.66%) and least in the self-care dimension (1.89%). In the value set, the maximum value was 1.000 for full health (health state ‘11111’) followed by the health state ‘11112’ with value 0.921. The minimum value was −0.865 for the worst state (‘55555’). Preference values were most affected by mobility and least by pain/discomfort. Conclusions: We now have a representative EQ-5D-5L value set for Indonesia. We expect our results will promote and facilitate health economic evaluations and HRQOL research in Indonesia

Fire and brief human occupations in Iberia during MIS 4: Evidence from Abric del Pastor (Alcoy, Spain)

There is a relatively low amount of Middle Paleolithic sites in Europe dating to MIS 4. Of the few that exist, several of them lack evidence for anthropogenic fire, raising the question of how this period of global cooling may have affected the Neanderthal population. The Iberian Peninsula is a key area to explore this issue, as it has been considered as a glacial refugium during critical periods of the Neanderthal timeline and might therefore yield archaeological contexts in which we can explore possible changes in the behaviour and settlement patterns of Neanderthal groups during MIS 4. Here we report recent data from Abric del Pastor, a small rock shelter in Alcoy (Alicante, Spain) with a stratified deposit containing Middle Palaeolithic remains. We present absolute dates that frame the sequence within MIS 4 and multi-proxy geoarchaeological evidence of in situ anthropogenic fire, including microscopic evidence of in situ combustion residues and thermally altered sediment. We also present archaeostratigraphic evidence of recurrent, functionally diverse, brief human occupation of the rock shelter. Our results suggest that Neanderthals occupied the Central Mediterranean coast of the Iberian Peninsula during MIS 4, that these Neanderthals were not undergoing climatic stress and they were habitual fire users.This research was funded by a Leakey Foundation General Grant, Spanish Ministry of Science, Innovation and Universities Projects HAR2008-06117/HIST and HAR2015-68321-P, Junta de Castilla y León-FEDER Project BU235P18, the LabEx Sciences Archéologiques de Bordeaux (LaScArBx ANR-10-LABX-52) and ERC Consolidator Grant ERC-CoG-2014. Archaeological excavations at Abric del Pastor are supported by the Archaeological Museum of Alcoy and the Government of Valencia Cultural Heritage Department

Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study

Background: Little is known about the healthcare process for patients with prostate cancer, mainly because hospital-based data are not routinely published. The main objective of this study was to determine the clinical characteristics of prostate cancer patients, the diagnostic process and the factors that might influence intervals from consultation to diagnosis and from diagnosis to treatment. Methods: We conducted a multicentre, cohort study in seven hospitals in Spain. Patients' characteristics and diagnostic and therapeutic variables were obtained from hospital records and patients' structured interviews from October 2010 to September 2011. We used a multilevel logistic regression model to examine the association between patient care intervals and various variables influencing these intervals (age, BMI, educational level, ECOG, first specialist consultation, tumour stage, PSA, Gleason score, and presence of symptoms) and calculated the odds ratio (OR) and the interquartile range (IQR). To estimate the random inter-hospital variability, we used the median odds ratio (MOR). Results: 470 patients with prostate cancer were included. Mean age was 67.8 (SD: 7.6) years and 75.4 % were physically active. Tumour size was classified as T1 in 41.0 % and as T2 in 40 % of patients, their median Gleason score was 6.0 (IQR:1.0), and 36.1 % had low risk cancer according to the D'Amico classification. The median interval between first consultation and diagnosis was 89 days (IQR:123.5) with no statistically significant variability between centres. Presence of symptoms was associated with a significantly longer interval between first consultation and diagnosis than no symptoms (OR:1.93, 95%CI 1.29-2.89). The median time between diagnosis and first treatment (therapeutic interval) was 75.0 days (IQR:78.0) and significant variability between centres was found (MOR:2.16, 95%CI 1.45-4.87). This interval was shorter in patients with a high PSA value (p = 0.012) and a high Gleason score (p = 0.026). Conclusions: Most incident prostate cancer patients in Spain are diagnosed at an early stage of an adenocarcinoma. The period to complete the diagnostic process is approximately three months whereas the therapeutic intervals vary among centres and are shorter for patients with a worse prognosis. The presence of prostatic symptoms, PSA level, and Gleason score influence all the clinical intervals differently